Microsoft ForeFront Client Security passes independent security test


 


Of the 35 anti-malware products tested in Virus Bulletin’s latest test, 23 products-- including Microsoft ForeFront Client Security--passed for detecting all of the 3,000 samples of malware while not detecting false positives. Twelve products failed the test. The products tested last month were anti-malware products for the 32-bit version of Windows Vista SP2 Business Edition. Here’s the list of products that passed the test:


 


·        AhnLab V3 Internet Security


·        Alwil avast! Professional


·        AVG Internet Security


·        Avira AntiVir Professional


·        CA eTrust ITM


·        eEye Blink Professional


·        ESET NOD32 Antivirus


·        Fortinet FortiClient


·        Frisk F-PROT antivirus


·        F-Secure Client Security


·        F-Secure PSB Workstation Security


·        G DATA AntiVirus 2010


·        Kaspersky Anti-Virus 2009


·        Kingsoft Internet Security 2009 Advanced


·        McAfee Total Security


·        McAfee VirusScan Enterprise


·        Microsoft Forefront Client Security


·        MWTI eScan Internet Security Suite
Nifty Corp. Security24


·        Norman Security Suite


·        Quick Heal AntiVirus Lite 2009


·        Sophos Anti-Virus


·        Trustport Antivirus 2009


 


And here are the products that failed:


 


·        Agnitum Outpost Security Suite Pro


·        CA Internet Security Suite


·        Filseclab Twister AntiTrojanVirus


·        Finport Simple Anti-Virus


·        K7 Total Security Desktop


·        Kingsoft Internet Security 2009 Standard


·        PC Tools AntiVirus 2009


·        PC Tools Internet Security 2009


·        PC Tools Spyware Doctor


·        Rising Internet Security 2009


·        Symantec Endpoint Protection


·        VirusBuster Professional


 


Virus Bulletin’s next test will be for anti-malware products for Windows Server 2008.


 



More to come,


Mitch


 


Subscribe to the TechNet Flash newsletter


 

Comments (0)

Skip to main content